Over the past decade, healthcare has been one of private equity’s most attractive sectors. Strong demand, favorable demographics, and clear operational upside fueled heavy deal activity across physician services, behavioral health, pharmacy, revenue cycle management, and beyond.

Today, many of those investments face a very different reality. The PE exit bottleneck has become especially pronounced in healthcare. According to recent data from Mergers and Acquisitions and PitchBook , the average hold period for a PE-backed healthcare company is now 6.4 years, which is nearly double what it was in 2020, creating mounting pressure on sponsors seeking liquidity.

Buyers remain active but highly selective, prioritizing only the strongest performers with clear growth, clean operations, and reliable financials. For many middle-market healthcare businesses, the combination of compressed EBITDA margins driven by persistent labor cost pressures and elevated debt service from high interest rates has squeezed both operating performance and returns, creating overleveraged balance sheets that are difficult to exit cleanly in a market where buyers can afford to be selective. Increasingly, AI is where operators and sponsors are turning to recover margin, improve transaction readiness, and close the gap on underwritten returns, with execution being the critical differentiator.

The State of PE-Backed Healthcare

Healthcare faces a unique mix of operational and financial pressure that hits enterprise value directly.

The first is workforce.For PE-backed healthcare operators, labor has been the most unrelenting margin headwind of the past several years. Clinical shortages have forced sustained dependence on expensive agency and contract staff, while a thin market for experienced coders and billing personnel has quietly eroded revenue cycle performance. Unlike most industries, healthcare operators cannot offset these cost increases through pricing, as reimbursement rates set by Medicare, Medicaid, and commercial payors create a hard ceiling that makes margin recovery almost entirely dependent on operational efficiency. The result is a cost structure that is both elevated and difficult to flex, limiting the EBITDA growth that sponsors need to support a clean exit.

The second is capital structure stress. Many middle-market healthcare assets were acquired at peak valuations with leverage levels that made sense when rates were near zero. The sharp rise in borrowing costs, with SOFR climbing from near zero to north of five percent in under two years, eroded free cash flow, elevated debt service burdens, and widened the gap between where sponsors need to exit and what buyers are willing to pay. The result is a cohort of assets that are neither distressed enough to force a sale nor performing well enough to command a premium, leaving sponsors caught between extended holds and returns that fall well short of original underwriting.

But there is a third pressure that quietly amplifies the other two, and it is the one most operators underestimate: fragmented data. Private equity fuels growth that outpaces infrastructure. Every acquisition arrives on its own EMR, practice-management system, and ERP, and nothing reconciles. As a result, the fundamentals go dark. Leaders cannot get a clean, fast answer on cash, denials, or provider productivity across sites, and the monthly operating report can take weeks to assemble.

When the foundation is that fragmented, analytics and AI never get off the ground, and the value-creation thesis stalls.

How AI Improves Exit Readiness

AI is emerging as one of the most powerful levers available to healthcare operators and investors, but where you start determines whether it works.

The instinct is to buy another niche solution or dashboard, but the more durable move is to fix the foundation first. Modern AI platforms can unify disconnected EMRs, billing systems, and ledgers into a single source of truth, often in days rather than quarters, giving management and prospective buyers one living view of the business. That foundation is what makes everything else possible, and it unlocks value in three escalating stages.

See the whole business.

One reconciled view of volume, revenue quality, denials, and productivity across every site and system, frequently for the first time.

Predict what is coming.

Forecast cash, demand, and denials before they hit. In the revenue cycle, that means scoring claims before submission and intercepting the denials that are otherwise unrecoverable, from timely-filing risk to missing medical-necessity documentation, so a clean claim goes out and revenue is protected.

Automate the work.

Agents act on the front lines, triaging prior authorizations and appeals, routing recovery work to the right owner, and surfacing the highest-impact actions, with a human approving anything that touches cash.

This is already happening. Autonomous coding, denial and A/R management, prior-authorization workflows, and contact-center operations are being automated to strengthen cash flow and cut administrative burden. For example, for one multi-site specialty group working with Teragonia, encounter-to-cash visibility was established for the first time, controllable denials were flagged for appeal, and a daily digest now pushes revenue-at-risk directly to operators and physicians, without anyone logging into a dashboard. For prospective buyers, organizations that can provide consistent operational, financial, and performance data are often easier to diligence, easier to underwrite, and easier to value. AI’s impact extends beyond efficiency gains; it can also improve transparency and transaction readiness.

Best Practices for Healthcare Organizations

As adoption accelerates, the hard part is knowing where to start. The market is crowded with vendors promising transformation. The organizations that win resist technology for its own sake and solve specific business problems in sequence:

1. Assess operational bottlenecks. Find the functions straining margin, workforce, or patient experience the most.
2. Establish a strong data foundation first. AI is only as good as the data underneath it. Prioritize integration, governance, and visibility before layering on advanced tools. This is the step most often skipped and most often regretted.
3. Focus on high-impact use cases. Revenue cycle, coding, scheduling, and labor optimization deliver measurable returns quickly.
4. Sequence from visibility to prediction to automation. Crawl, walk, run. Earn trust in the data, then forecast, then automate, rather than reaching for autonomy before the foundation can support it.
5. Align every AI initiative with the exit. Whether the goal is profitability, efficiency, or transaction readiness, the payoff compounds at exit, when clean data and diligence-ready reporting translate directly into buyer confidence and a defensible valuation.

Reimbursement pressure, workforce shortages, and underperforming investments will not vanish overnight, but AI, applied foundation-first, is a real path forward.

As IPO and M&A markets regain momentum, operational excellence will increasingly separate assets that achieve liquidity from those that remain in extended hold periods.

Organizations that establish a strong data foundation today will be better positioned not only to deploy AI successfully, but also to demonstrate the transparency, performance, and scalability that buyers increasingly demand.